|
GnRH antagonist Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 1: 1Phase 2/3: 1
Top Sponsors
- Xiaojun Chen1
- Amgen1
Indications
- Cancer2
- Progesterone Resistance1
- Atypical Endometrial Hyperplasia1
- Endometrial Neoplasms1
- Obesity1
Other1 trial
San Francisco, California1 trial
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
University of California San Francisco
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.